KDR and pulmonary arterial hypertension: In our study, cardiac catheterization, echocardiography and MRI confirmed that animals treated once with the VEGFR2 inhibitor SU5416, followed by subsequent hypoxia for 3 weeks, developed severe PAH and right heart failure.